Single nucleotide polymorphisms of the 5-HT1A receptor and TPH2 have been suggested to interact with the severity of depression and respond to SSRIs (Serretti et al., 2011; Jacobsen et al., 2012). The gene discussed is HTR1A; the disease is major depressive disorder.